• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

GRN No. 455

Substance: Bifidobacterium breve M-16V
Intended Use: As an ingredient in exempt term powdered amino acid-based formulas, at levels providing 108 colony forming units per gram of infant formula powder
Basis: Scientific procedures
Notifier: Danone Trading B.V.
Schiphol Boulevard 105
1118 BG Schiphol Airport
THE NETHERLANDS
Date of filing: Jan 23, 2013
GRAS Notice (releasable information): 455
Date of closure / FDA's Letter: Sep 30, 2013
FDA has no questions
-
-